4//SEC Filing
Krempa David 4
Accession 0001437749-24-030714
CIK 0001710340other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:19 PM ET
Size
5.5 KB
Accession
0001437749-24-030714
Insider Transaction Report
Form 4
Krempa David
Chief Business Officer
Transactions
- Award
Restricted Stock Units
2024-10-02+42,088→ 861,374 total→ Common Stock (42,088 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F2]The restricted stock units vest in four equal annual installments beginning October 2, 2025, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001968254
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:19 PM ET
- Size
- 5.5 KB